Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer

NCT04486352 is registered in ClinicalTrials.gov with Alliance Foundation Trials, LLC. as lead sponsor.

NCT NCT04486352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer
Lead sponsor
Alliance Foundation Trials, LLC.
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 20, 2021
Completion date
October 31, 2027
Enrollment
148 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer